TAMPA, Fla., March 10, 2020 /PRNewswire/ -- Tampa General Hospital and the USF Health Morsani College of Medicine are strengthening their long-standing relationship by joining Tampa General Medical Group and USF Health physician group, which will create one of the largest academic medical center physician groups in the state of Florida

SAN FRANCISCO, March 10, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, announced today the acquisition of Diploid, a privately held

SAN FRANCISCO, March 10, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced it has entered into definitive agreements to

WALTHAM, Mass., March 10, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Paul G. Parker will join the company, effective April 15, 2020, as senior vice president, strategy and corporate development, which also includes corporate soc

CLEVELAND, March 10, 2020 /PRNewswire/ -- With the rapid spread of the new coronavirus, COVID-19, monitoring temperatures of infected or exposed patien

SAN DIEGO, March 10, 2020 /PRNewswire/ -- CBD products are gaining popularity among consumers. Many people have been able to improve their quality of life thanks to various CBD offerings. Often, they will recommend these products to their relatives and friends. CBD manufacturers are responsive to the growing demand and are ready to offer a wide selection of CBD products

NEWARK, Calif., March 10, 2020 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported its financial results for the fourth quarter and full year ended December 31, 2019, and provided an update on its clinical development programs."We are pleased to have made great progress in 2019, creating multiple opportuni

RARITAN, N.J., March 10, 2020 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for JNJ-61186372 (JNJ-6372) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EG

LEE'S SUMMIT, Mo., March 10, 2020 /PRNewswire/ -- Viracor Eurofins, in accordance with the FDA Emergency Use Authorization Guidance, announces it will start testing specimens for Coronavirus SARS-CoV-2 RT-PCR as of March 13, 2020.  The new test utilizes real-time reverse-transcriptase polymerase chain reaction (RT-PCR) technology a

LONG BEACH, Calif., March 10, 2020 /PRNewswire/ -- Today, SCAN announced that Chris Wing, Chief Executive Officer of SCAN, will transition from his current position by the end of 2020. He will remain CEO and a member of the Board of Directors until his successor is in place.